4.42 USD
+0.01 (+0.23%)
At close: Jan 29, 2026
4.4222 USD
+0 (+0.05%)
After Hours: 1/29/2026, 8:00:02 PM
ChartMill assigns a Buy % Consensus number of 86% to SABS. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 9.56. This target is 116.35% above the current price.
- SABS was analyzed by 13 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about SABS.
- In the previous month the buy percentage consensus was at a similar level.
- SABS was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-07 | UBS | Initiate | Buy |
| 2025-12-19 | Guggenheim | Initiate | Buy |
| 2025-12-18 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-11-17 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-09-19 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-09-17 | Leerink Partners | Initiate | Outperform |
| 2025-08-08 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-07-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-15 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-04-01 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-04-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-29 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-01-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-07 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-10-09 | Craig-Hallum | Initiate | Buy |
| 2024-09-12 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-09-09 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-08-28 | Oppenheimer | Initiate | Outperform |
| 2024-08-12 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-08-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-07 | Brookline Capital | Initiate | Buy |
| 2024-05-21 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-05-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-16 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-04-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-02 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-04-02 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-01-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-10-05 | Ladenburg Thalmann | Downgrade | Buy -> Neutral |
SAB BIOTHERAPEUTICS INC / SABS FAQ
What do analysts expect the price target to be for SAB BIOTHERAPEUTICS INC (SABS)?
13 analysts have analysed SABS and the average price target is 9.56 USD. This implies a price increase of 116.35% is expected in the next year compared to the current price of 4.42.
What is the consensus rating for SABS stock?
The consensus rating for SAB BIOTHERAPEUTICS INC (SABS) is 86.1538 / 100 . This indicates that analysts generally have a positive outlook on the stock.